Tutorials
Merck & Co Inc logo

Merck & Co Inc

ARS 5230.50 (+3.84%) Aug 12
P/E:
13.97
P/B:
5.34
Market Cap:
ARS 30.96T ($ 230.10B)
Enterprise V:
ARS 33.85T ($ 251.59B)
Volume:
1.33K
Avg Vol (2M):
1.24K
Also Trade In:
Volume:
1.33K
Market Cap ARS:
30.96T
Market Cap $:
230.10B
PE Ratio:
13.97
Avg Vol (2-Month):
1.24K
Enterprise Value ARS:
33.85T
Enterprise Value $:
251.59B
PB Ratio:
5.34
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Merck & Co Inc
NAICS : 325412 SIC : 2834
2000 Galloping Hill Road, Kenilworth, NJ, USA, 07033
Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.

Financials (Next Earnings Date:2022-10-27)

BUE:MRK's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ARS) 6,114,982.624
EPS (TTM) (ARS) 6945.132
Beta 0
Volatility % 46.86
14-Day RSI 50.65
14-Day ATR (ARS) 215.129192
20-Day SMA (ARS) 5428.725
12-1 Month Momentum % 105.81
52-Week Range (ARS) 2561 - 6178.5
Shares Outstanding (Mil) 253.33

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Merck & Co Inc Filings

Document Form Filing Date
No Filing Data